Learn More
Apexbio Technology LLC Granzyme B Inhibitor Z-AAD-CH2Cl 20ul (10 mM)

Supplier: Apexbio Technology LLC B59660.02
Granzyme B Inhibitor Z-AAD-CH2Cl is a small-molecule inhibitor targeting granzyme B a serine protease predominantly expressed in cytotoxic lymphocytes natural killer (NK) cells and cytotoxic T lymphocytes (CTLs) It is designed to irreversibly inhibit granzyme B activity thereby modulating apoptosis induction and immune regulation Granzyme B Inhibitor Z-AAD-CH2Cl exerts its biological activity primarily through irreversible inhibition of granzyme B In cell-based studies it demonstrates inhibitory activity in models such as NK cell-induced cytotoxicity in chondrocytes lymphocyte-induced caspase-3 activation and DNA fragmentation and activation-induced apoptosis in T-cell populations Based on these pharmacological properties Granzyme B Inhibitor Z-AAD-CH2Cl holds research potential in immunology oncology and inflammation-related disorders
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.